© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to August
potent and selective SOS1/KRAS inhibitor
related cmpd in Ph. I for KRAS+ cancers
from biochemical HTS and SBDD
Cancer Discovery, Aug. 19, 2020
Boehringer Ingelheim, Vienna, AT
BI-3406 is a compound which binds to SOS1, preventing it from activating the oncoprotein KRAS. While inhibition of WT-KRAS and MEK alone are anticipated to be toxic, the combination of…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.